We use cookies for a better user experience. Read our Privacy Policy

I Agree

Sirolimus Market

Sirolimus Market (Application - Organ Transplant Rejection, Lymphangioleiomyomatosis(LAM), Sirolimus Coated Balloons and Catheter Devices; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Sirolimus: A Multi-action Promising Drug

Sirolimus could have a promising role in prophylaxis of rejection, treatment of refractory acute rejection, and chronic allograft dysfunction, as substantiated by various studies. Sirolimus is a new potent immunosuppressant whose profile could offer an advantage over other currently used drugs in view of its absence of intrinsic nephrotoxicity and efficacy as good as cyclosporin. Sirolimus could have both, a steroid sparing as well as a cyclosporin sparing effect.

Sirolimus may have a beneficial role in prophylaxis of rejection as well as treatment of refractory rejection. Sirolimus also has antifungal, antitumor, and anti-smooth muscle proliferative roles. The global sirolimus market was valued at US$ 285.00 Mn in 2018 and is projected to reach US$ 304.08 Mn by 2027, expanding at a CAGR of 1.0% from 2019 to 2027.

Promising Pipeline Opening New Market Opportunities

  • Increase in incidence of target diseases, rise in the number of lifestyle-related disorders, promising pipeline, surge in health care spending, and improvement in health care infrastructure are the factors anticipated to drive the global sirolimus market.
  • Furthermore, increase in preference for generic drug variants and associated side effects are expected to restrain the Sirolimus market.

sirolimus market 3

Global Sirolimus Market: Report Segmentation

  • In terms of application, the global sirolimus market has been categorized into organ transplant rejection, lymphangioleiomyomatosis (LAM), and sirolimus coated balloons & catheter devices.

sirolimus market 2

  • The organ transplant rejection segment dominated the sirolimus market in 2018 due to rise in the number of organ transplants.
  • Based on distribution channel, the global sirolimus market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies.
  • In terms of region, the global sirolimus market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • North America accounted for major share of the global sirolimus market in 2018. The market in the region is driven by the presence of key players and high rate of adoption of technologies.
    • Additionally, rise in the number of organ transplants is projected to propel the market in North America.
    • Increase in incidence of target diseases, rise in prevalence of lifestyle-related disorders, promising pipeline, and surge in health care spending & improvement in health care infrastructure is anticipated to boost market growth.

Global Sirolimus Market: Competitive Insights

The global sirolimus market is highly fragmented due to the presence of a large number of players. Major players operating in the market include Pfizer, Inc., Biocon, Dr. Reddy’s Laboratories Ltd., Concept Medical, Inc., Stentys SA, Torrent Pharmaceuticals Ltd., Zydus Cadila, and Intas Pharmaceuticals Ltd.

Increase in trend of mergers & acquisitions and product approvals & launches in developing countries is expected to boost the global sirolimus market during the forecast period. Additionally, acquisitions drive growth in core business. Product approvals enable companies to enhance product portfolio globally.

The global sirolimus market has been segmented as follows:

  • Global Sirolimus Market, by Application
    • Organ Transplant Rejection
    • Lymphangioleiomyomatosis (LAM)
    • Sirolimus Coated Balloons & Catheter Devices
  • Global Sirolimus Market, by Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Sirolimus Market, by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

The global Sirolimus market has been segmented as follows:

Application

  • Organ Transplant Rejection
  • Lymphangioleiomyomatosis (LAM)
  • Sirolimus Coated Balloons & Catheter Devices

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe 
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa
Sirolimus Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global sirolimus market in 2018?

Sirolimus market was valued at US$ 285.00 Mn in 2018

What is the total market worth of sirolimus market?

Sirolimus market is projected to reach US$ 304.08 Mn by 2027

What is the anticipated CAGR of the sirolimus market in the forecast period?

Sirolimus market to expand at a CAGR of 1.0% from 2019 to 2027

What are the key driving factors for the growth of the sirolimus market?

Sirolimus market is driven by increase in incidence of target diseases, rise in the number of lifestyle-related disorders

Who are the key players in the sirolimus market?

Key players in the sirolimus market include Pfizer, Inc., Biocon, Dr. Reddy’s Laboratories Ltd., Concept Medical, Inc., Stentys SA

1. Preface
       1.1. Market Definition and Scope
       1.2. Market Segmentation
       1.3. Key Research Objectives
       1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sirolimus Market 

4. Market Overview
       4.1. Introduction
                4.1.1. Application Definition
                4.1.2. Industry Evolution / Developments
       4.2. Overview
       4.3. Market Dynamics
                4.3.1. Drivers
                4.3.2. Restraints
                4.3.3. Opportunities
       4.4. Global Sirolimus Market Analysis and Forecast, 2016–2026

5. Market Outlook
       5.1.Disease Prevalence & Incidence Rate globally with key countries
       5.2.Pipeline Analysis
       5.3.Supply Chain Analysis
       5.4.Pricing Analysis by Product & Manufacturers
       5.5.Global Sirolimus Market, by Consumption Volume (Kg) (2018)
       5.6.Overview of Sirolimus Manufacturing Process

6. Global Sirolimus Market Analysis and Forecast, by Application 
       6.1. Introduction & Definition
       6.2. Key Findings / Developments
       6.3. Market Value Forecast, by Application, 2016–2026
                6.3.1. Organ Transplant Rejection
                6.3.2. Lymphangioleiomyomatosis (LAM)
                6.3.3. Sirolimus Coating Balloon & Catheter Devices 
       6.4. Market Attractiveness, by Application 

7. Global Sirolimus Market Analysis and Forecast, by Distribution Channel 
       7.1. Introduction & Definition
       7.2. Key Findings / Developments
       7.3. Market Value Forecast, by Distribution Channel, 2016–2026
                7.3.1. Hospital Pharmacies
                7.3.2. Retail Pharmacies
                7.3.3. Online Pharmacies
       7.4. Market Attractiveness, by Distribution Channel 

8. Global Sirolimus Market Analysis and Forecasts, by Region
       8.1. Key Findings
       8.2. Market Value Forecast, by Region
                8.2.1. North America 
                8.2.2. Europe 
                8.2.3. Asia Pacific 
                8.2.4. Latin America 
                8.2.5. Middle East & Africa 
       8.3. Market Attractiveness, by Country/Region

9. North America Sirolimus Market Analysis and Forecast
       9.1. Introduction
                9.1.1. Key Findings
       9.2. Market Value Forecast, by Application, 2016–2026
                9.2.1. Organ Transplant Rejection
                9.2.2. Lymphangioleiomyomatosis (LAM)
                9.2.3. Sirolimus Coating Balloon & Catheter Devices 
       9.3. Market Value Forecast, by Distribution Channel, 2016–2026
                9.3.1. Hospital Pharmacies
                9.3.2. Retail Pharmacies
                9.3.3. Online Pharmacies
       9.4. Market Value Forecast, by Country, 2016–2026
                9.4.1. U.S.
                9.4.2. Canada
       9.5. Market Attractiveness Analysis 
                9.5.1. By Application 
                9.5.2. By Distribution Channel 
                9.5.3. By Country

10. Europe Sirolimus Market Analysis and Forecast
       10.1. Introduction
                10.1.1. Key Findings
       10.2. Market Value Forecast, by Application, 2016–2026
                10.2.1. Organ Transplant Rejection
                10.2.2. Lymphangioleiomyomatosis (LAM)
                10.2.3. Sirolimus Coating Balloon & Catheter Devices 
       10.3. Market Value Forecast, by Distribution Channel, 2016–2026
                10.3.1. Hospital Pharmacies
                10.3.2. Retail Pharmacies
                10.3.3. Online Pharmacies
       10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
                10.4.1. Germany
                10.4.2. U.K.
                10.4.3. France
                10.4.4. Spain
                10.4.5. Italy
                10.4.6. Rest of Europe
       10.5. Market Attractiveness Analysis 
                10.5.1. By Application 
                10.5.2. By Distribution Channel 
                10.5.3. By Country/Sub-region

11. Asia Pacific Sirolimus Market Analysis and Forecast
       11.1.Introduction
                11.1.1. Key Findings
       11.2.Market Value Forecast, by Application, 2016–2026
                11.2.1. Organ Transplant Rejection
                11.2.2. Lymphangioleiomyomatosis (LAM)
                11.2.3. Sirolimus Coating Balloon & Catheter Devices 
       11.3.Market Value Forecast, by Distribution Channel, 2016–2026
                11.3.1. Hospital Pharmacies
                11.3.2. Retail Pharmacies
                11.3.3. Online Pharmacies
       11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
                11.4.1. China
                11.4.2. Japan
                11.4.3. India
                11.4.4. Australia & New Zealand
                11.4.5. Rest of Asia Pacific
       11.5. Market Attractiveness Analysis 
                11.5.1. By Application 
                11.5.2. By Distribution Channel 
                11.5.3. By Country/Sub-region

12. Latin America Sirolimus Market Analysis and Forecast
       12.1.Introduction
                12.1.1. Key Findings
       12.2. Market Value Forecast, by Application, 2016–2026
                12.2.1. Organ Transplant Rejection
                12.2.2. Lymphangioleiomyomatosis (LAM)
                12.2.3. Sirolimus Coating Balloon & Catheter Devices 
       12.3. Market Value Forecast, by Distribution Channel, 2016–2026
                12.3.1. Hospital Pharmacies
                12.3.2. Retail Pharmacies
                12.3.3. Online Pharmacies
       12.4. Market Value Forecast, by Country/Sub-region, 2016–2026
                12.4.1. Brazil
                12.4.2. Mexico
                12.4.3. Rest of Latin America
       12.5. Market Attractiveness Analysis 
                12.5.1. By Application 
                12.5.2. By Distribution Channel 
                12.5.3. By Country/Sub-region

13. Middle East & Africa Sirolimus Market Analysis and Forecast
       13.1. Introduction
                13.1.1. Key Findings
       13.2. Market Value Forecast, by Application, 2016–2026
                13.2.1. Organ Transplant Rejection
                13.2.2. Lymphangioleiomyomatosis (LAM)
                13.2.3. Sirolimus Coating Balloon & Catheter Devices 
       13.3. Market Value Forecast, by Distribution Channel, 2016–2026
                13.3.1. Hospital Pharmacies
                13.3.2. Retail Pharmacies
                13.3.3. Online Pharmacies
       13.4. Market Value Forecast, by Country/Sub-region, 2016–2026
                13.4.1. GCC Countries
                13.4.2. South Africa
                13.4.3. Israel
                13.4.4. Rest of Middle East & Africa
       13.5. Market Attractiveness Analysis 
                13.5.1. By Application 
                13.5.2. By Distribution Channel 
                13.5.3. By Country/Sub-region

14. Competition Landscape
       14.1. Market Player - Competition Matrix (By Tier and Size of companies)
       14.2. Market Share Analysis, by Company (2018)
       14.3. Company Profiles
                14.3.1. Pfizer, Inc. 
                14.3.2. Biocon
                14.3.3. Dr. Reddy’s Laboratories Ltd. 
                14.3.4. Concept Medical, Inc. 
                14.3.7. Stentys SA 
                14.3.8. Torrent Pharmaceuticals Ltd. 
                14.3.9. Zydus Cadila 
                14.3.10. Intas Pharmaceuticals Ltd.      

List of Tables
Table 01-10: Pipeline Analysis
Table 11: Global Sirolimus Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 12: Global Sirolimus Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 13: Global Sirolimus Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 14: North America Sirolimus Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
Table 15: North America Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 16: North America Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 17: Europe Sirolimus Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
Table 18: Europe Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 19: Europe Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 20: Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 22: Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 23: Latin America Sirolimus Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Latin America Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 25: Latin America Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 26: Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 27: Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 28: Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027

 

List of Figures 
Figure 01: Global Sirolimus Market Value (US$ Mn) and Distribution, by Region, 2019 and 2027
Figure 02: Market Snapshot
Figure 04: Global Sirolimus Market Value Share, by Distribution Channel (2018)
Figure 03: Global Sirolimus Market Value Share, by Application (2018)
Figure 05: Global Sirolimus Market Value Share, by Region (2018)
Figure 06: Global Sirolimus Market Size (US$ Mn) Forecast, 2017–2027
Figure 07: Global Sirolimus Market Value Share Analysis, by Application, 2018 and 2027
Figure 08: Global Sirolimus Market Revenue (US$ Mn) Forecast, 2017–2027, by Organ Transplant Rejection
Figure 09: Global Sirolimus Market Revenue (US$ Mn) Forecast, 2017–2027, by Lymphangioleiomyomatosis (LAM)
Figure 10: Global Sirolimus Market Revenue (US$ Mn) Forecast, 2017–2027, by Sirolimus Coating Balloon & Catheter Devices 
Figure 11: Global Sirolimus Market Attractiveness, by Application, 2019–2027
Figure 12: Global Sirolimus Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 13: Global Sirolimus Market Revenue (US$ Mn) Forecast, by Hospital Pharmacies, 2017–2027
Figure 14: Global Sirolimus Market Revenue (US$ Mn) Forecast, by Retail Pharmacies, 2017–2027
Figure 15: Global Sirolimus Market Revenue (US$ Mn) Forecast, by Online Pharmacies, 2017–2027
Figure 16: Global Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
Figure 17: Global Sirolimus Market Value Share Analysis, by Region, 2018 and 2027
Figure 18: Sirolimus Market Attractiveness Analysis, by Region
Figure 19: North America Sirolimus Market Revenue (US$ Mn) Forecast, 2017–2027
Figure 20: North America Sirolimus Market Value Share (%), by Country, 2018 and 2027
Figure 21: North America Sirolimus Market Attractiveness, by Country, 2019–2027
Figure 22: North America Sirolimus Market Value Share (%), by Application, 2018 and 2027
Figure 23: North America Sirolimus Market Attractiveness, by Application, 2019–2027
Figure 24: North America Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 25: North America Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
Figure 26: Europe Sirolimus Market Revenue (US$ Mn) Forecast, 2017–2027
Figure 27: Europe Sirolimus Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 28: Europe Sirolimus Market Attractiveness, by Country, 2019–2027
Figure 29: Europe Sirolimus Market Value Share (%), by Application, 2018 and 2027
Figure 30: Europe Sirolimus Market Attractiveness, by Application, 2019–2027
Figure 31: Europe Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 32: Europe Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
Figure 33: Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, 2017–2027
Figure 34: Asia Pacific Sirolimus Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 35: Asia Pacific Sirolimus Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 36: Asia Pacific Sirolimus Market Value Share (%), by Application, 2018 and 2027
Figure 37: Asia Pacific Sirolimus Market Attractiveness, by Application, 2019–2027
Figure 38: Asia Pacific Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 39: Asia Pacific Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
Figure 40: Latin America Sirolimus Market Revenue (US$ Mn) Forecast, 2017–2027
Figure 41: Latin America Sirolimus Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 42: Latin America Sirolimus Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 43: Latin America Sirolimus Market Value Share (%), by Application, 2018 and 2027
Figure 44: Latin America Sirolimus Market Attractiveness, by Application, 2019–2027
Figure 45: Latin America Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 46: Latin America Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
Figure 47: Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, 2017–2027
Figure 48: Middle East & Africa Sirolimus Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 49: Middle East & Africa Sirolimus Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 50: Middle East & Africa Sirolimus Market Value Share (%), by Application, 2018 and 2027
Figure 51: Middle East & Africa Sirolimus Market Attractiveness, by Application, 2019–2027
Figure 52: Middle East & Africa Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 53: Middle East & Africa Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
Figure 54: Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 55: Pfizer, Inc. Breakdown of Net Sales (%), by Region, 2018
Figure 56: Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 57: Pfizer, Inc. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 58: Biocon Branded Formulations Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 59: Biocon Breakdown of Net Sales (%), by Region, 2018
Figure 60: Biocon R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 61: Biocon Breakdown of Net Sales (%), by Business Segment, 2018
Figure 62: Dr. Reddy’s Laboratories Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 63: Dr. Reddy’s Laboratories Ltd. Breakdown of Net Sales (% Share), by Region (2018)
Figure 64: Dr. Reddy’s Laboratories Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 65: Dr. Reddy’s Laboratories Ltd. Breakdown of Net Sales (% Share), by Business Segment (2018)
Figure 66: Zydus Cadila Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 67: Zydus Cadila Breakdown of Net Sales (%), by Region, 2018
Figure 68: Zydus Cadila Pharmaceutical Business Segment R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
 Figure 69:  Intas Pharmaceuticals Ltd. Intas Pharmaceuticals Ltd. Pharmaceuticals Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 70: STENTYS SA Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 71: STENTYS SA R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 72: Torrent Pharmaceuticals Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Torrent Pharmaceuticals Ltd. Breakdown of Net Sales (%), by Region, 2018
Figure 74: Torrent Pharmaceuticals Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

119

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved